Im SA - Search Results

1

First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer.

Park SH, Bang SM, Cho EK, Baek JH, Oh JH, Im SA, Park YS, Shin DB, Lee JH. Park SH, et al. Among authors: im sa. Oncology. 2004;66(5):353-7. doi: 10.1159/000079482. Oncology. 2004. PMID: 15331921 Clinical Trial.

2

A multi-center, late phase II clinical trial of Genexol (paclitaxel) and cisplatin for patients with advanced gastric cancer.

Park SR, Oh DY, Kim DW, Kim TY, Heo DS, Bang YJ, Kim NK, Kang WK, Kim HT, Im SA, Suh JH, Kim HK, Kim HK. Park SR, et al. Among authors: im sa. Oncol Rep. 2004 Nov;12(5):1059-64. Oncol Rep. 2004. PMID: 15492793 Clinical Trial.

3

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib.

Han SW, Kim TY, Hwang PG, Jeong S, Kim J, Choi IS, Oh DY, Kim JH, Kim DW, Chung DH, Im SA, Kim YT, Lee JS, Heo DS, Bang YJ, Kim NK. Han SW, et al. Among authors: im sa. J Clin Oncol. 2005 Apr 10;23(11):2493-501. doi: 10.1200/JCO.2005.01.388. Epub 2005 Feb 14. J Clin Oncol. 2005. PMID: 15710947 Clinical Trial.

4

Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer.

Lee KW, Kim JH, Yun T, Song EK, Na II, Shin H, Oh SY, Choi IS, Oh DY, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK. Lee KW, et al. Among authors: im sa. J Korean Med Sci. 2007 Sep;22 Suppl(Suppl):S115-21. doi: 10.3346/jkms.2007.22.S.S115. J Korean Med Sci. 2007. PMID: 17923737 Free PMC article. Clinical Trial.

5

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer.

Han SW, Hwang PG, Chung DH, Kim DW, Im SA, Kim YT, Kim TY, Heo DS, Bang YJ, Kim NK. Han SW, et al. Among authors: im sa. Int J Cancer. 2005 Jan 1;113(1):109-15. doi: 10.1002/ijc.20550. Int J Cancer. 2005. PMID: 15386420 Clinical Trial.

6

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.

Lee KS, Chung HC, Im SA, Park YH, Kim CS, Kim SB, Rha SY, Lee MY, Ro J. Lee KS, et al. Among authors: im sa. Breast Cancer Res Treat. 2008 Mar;108(2):241-50. doi: 10.1007/s10549-007-9591-y. Epub 2007 May 3. Breast Cancer Res Treat. 2008. PMID: 17476588 Clinical Trial.

7

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group. Baselga J, et al. Among authors: im yh, im sa. N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7. N Engl J Med. 2012. PMID: 22149875 Free PMC article. Clinical Trial.

8

Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine.

Pivot X, Im SA, Guo M, Marmé F. Pivot X, et al. Among authors: im sa. Breast Cancer. 2018 May;25(3):370-374. doi: 10.1007/s12282-017-0826-4. Epub 2018 Jan 4. Breast Cancer. 2018. PMID: 29302858 Free PMC article. Clinical Trial.

9

Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy.

Kim HJ, Lee MH, Lee JE, Park S, Lee ES, Kang YJ, Shin HN, Kim SI, Lee JH, Im SA, Ahn SH, Lee KS, Sohn J, Kim S, Nam SJ, Han W. Kim HJ, et al. Among authors: im sa. Clin Breast Cancer. 2018 Oct;18(5):e1165-e1172. doi: 10.1016/j.clbc.2018.04.008. Epub 2018 Apr 19. Clin Breast Cancer. 2018. PMID: 29843988

10

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.

Cortes J, Rugo HS, Cescon DW, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Torregroza Otero M, Gokmen E, Loi S, Guo Z, Zhou X, Karantza V, Pan W, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. Among authors: im sa. N Engl J Med. 2022 Jul 21;387(3):217-226. doi: 10.1056/NEJMoa2202809. N Engl J Med. 2022. PMID: 35857659 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

703 results

Search Page

Filters